The Autophagy Receptor


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 Sep 2024
Historique:
received: 29 05 2024
revised: 23 08 2024
accepted: 05 09 2024
medline: 29 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

(1) Background: Intrinsic defense mechanisms are pivotal host strategies to restrict viruses already at early stages of their infection. Here, we addressed the question of how the autophagy receptor sequestome 1 (

Identifiants

pubmed: 39339916
pii: v16091440
doi: 10.3390/v16091440
pii:
doi:

Substances chimiques

Sequestosome-1 Protein 0
SQSTM1 protein, human 0
Viral Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : ZI 1810/1-1
Organisme : Deutsche Forschungsgemeinschaft
ID : PL 236/7-1
Organisme : Dr. Rolf M. Schweite Stiftung
ID : project 13/2017
Organisme : LOEWE Zentrum Frankfurt Cancer Institute Discovery & Development grant
ID : grant 21001366
Organisme : Goethe University Frankfurt Nachwuchswissenschaftler grant
ID : 710000624
Organisme : GRADE A/B Focus
ID : PID003790

Auteurs

Nadine Krämer (N)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Uxía Gestal Mato (UG)

Institute of Biochemistry II (IBC2), Goethe University School of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.

Steffi Krauter (S)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Nicole Büscher (N)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Ahmad Afifi (A)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Lina Herhaus (L)

Institute of Biochemistry II (IBC2), Goethe University School of Medicine, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany.

Luise Florin (L)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Bodo Plachter (B)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Christine Zimmermann (C)

Institute for Virology and Forschungszentrum Immuntherapie, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH